St. Francis hospitals getting Franciscan Alliance name
The Mishawaka-based health system’s move comes after months of consumer research—and six months after rival system Clarian Health said it would change its name to Indiana University Health.
Health Care & Life Sciences
Articles
State joins push to protect elderly from financial scams
Indiana doctors may soon check on patients’ financial health as part of a program that teaches health care providers how to spot victims of swindlers.
Dow AgroSciences moves into new research facility
The division of Dow Chemical has a 15-year lease with Indianapolis-based developer Browning Investments on the two-story building near West 96th Street.
Community, Westview hospitals in ‘strategic alliance’ talks
The form an alliance would take is not clear, but Westview looked for additional resources from city’s four major hospital systems.
City approves Beckman Coulter tax abatement
The tax abatement is tied to an expansion in which the company plans to invest $18 million in its Indianapolis operations and add as many as 95 jobs in the next three years.
Q&A
Les Zwirn, executive director of Better Healthcare for Indiana, talked about his group’s progress on promoting community collaborations to improve health and reduce the cost of care in cities around Indiana. BHI is hosting its third health care summit of Indiana community leaders today at Second Presbyterian Church in Indianapolis.
Lilly scores series of small victories
The Indianapolis-based drugmaker finally won FDA approval for its antidepressant Cymbalta to treat chronic pain and fended off a patent challenge to rising-star cancer drug Alimta, but got a ratings downgrade on its debt.
Court upholds Lilly patent on cancer drug Alimta
A U.S. District Court judge on Monday upheld Eli Lilly and Co.’s patent on the cancer drug Alimta, protecting the compound until July 2016. It was a welcome win after a difficult few months for Indianapolis-based Lilly, which is facing a wave of patent expirations in coming years.
Study: Arthritis drug co-developed by Lilly shows promise
Lilly paid $90 million in 2009 to acquire the global rights to the treatment in a bid to beef up its pipeline of medications for autoimmune diseases.
Audit: Indiana owes feds $39M for Medicaid
A federal audit recommends that Indiana's human services agency refund the federal government nearly $39 million it overpaid to Medicaid providers during a nine-year period.
Drugmaker restarts race to boost ‘good’ cholesterol
Merck & Co. is betting it can succeed where Pfizer Inc. failed, with a new type of drug to combat heart disease by raising good cholesterol levels. Indianapolis-based Eli Lilly and Co. is testing a similar pill.
Nurse practitioners get some autonomy
Could nurse practitioners get a promotion in the medical field? At least one health insurer is treating them like doctors now.
Acquisition big step for Lilly Diagnostics
Eli Lilly and Co.’s $800 million acquisition of Avid Radiopharmaceuticals Inc. is the biggest step yet in the drugmaker’s attempt to add diagnostics to its product portfolio.
Study: Substance abuse treatment costly for state
A study at the Center for Health Policy at IUPUI found that 66 cents of every dollar the state spends on services related to substance abuse goes toward health care while only 1 cent goes toward prevention or intervention.
Lilly wins approval of antidepressant Cymbalta for pain
The Food and Drug Administration has cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back conditions, which could mean another $500 million in annual sales for Lilly, an analyst estimates.
Drama builds in suit over Hilbert mother-in-law’s life policy
Businessman J.B. Carlson is in debt for $5.9 million, and he may have been the last person to see 74-year-old Suzy Tomlinson alive. Her $15 million life-insurance policy named him as the beneficiary.
Indiana health exchange may take page from Utah playbook
In Utah, employers can give each of their workers a specific amount of money to apply toward health insurance. The worker then can use that money to choose from the 66 plans in the health insurance exchange.
Indiana life sciences upstarts tap health reform booty
The federal legislation is roundly criticized at a BioCrossroads meeting, but some firms have found a silver lining.
WellPoint boosts third-quarter profit, raises forecast
The Indianapolis-based health insurer raised its full-year profit forecast by 20 cents per share, after lower-than-expected claims and lower administrative costs increased third-quarter profit by 1 percent.
Q&A: Jim Hamilton
Jim Hamilton, an employee-benefits lawyer at Bose McKinney & Evans in Indianapolis, discussed the likelihood of a Republican-controlled U.S. House of Representatives changing or even outright repealing the health care reform law, formally known as the Patient Protection and Affordable Care Act.